Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents (Q37187507)

18 August 2017

1 reference

title

Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents (English)

1 reference

nephrogenic systemic fibrosis

18 August 2017

1 reference

0 references

1 reference

Jeffrey G Penfield

1

1 reference

PubMed ID

18543004

18 August 2017

language of work or name

1 reference

10 June 2008

1 reference

18 August 2017

1 reference

18 August 2017

23

1 reference

18 August 2017

12

1 reference

18 August 2017

2121-2129

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-008-0862-6

18 August 2017

0 references

cites work

The Spanish toxic oil syndrome 20 years after its onset: a multidisciplinary review of scientific knowledge

1 reference

https://api.crossref.org/works/10.1007%2FS00467-008-0862-6

Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-008-0862-6

Hair and fingernail gadolinium ICP-MS contents in an overdose case associated with nephrogenic systemic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-008-0862-6

Gadolinium-containing contrast media for radiographic examinations: a position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-008-0862-6

Gadolinium-enhanced T(1)-weighted MR urography versus T(2)-weighted (HASTE) MR urography in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-008-0862-6

Nephrogenic systemic fibrosis: relationship to gadolinium and response to photopheresis

21 January 2018

1 reference

12 December 2020

Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: report of a new case with literature review

1 reference

12 December 2020

Evaluating the role of recombinant erythropoietin in nephrogenic systemic fibrosis

1 reference

12 December 2020

A case of nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.

1 reference

12 December 2020

Risk for nephrogenic systemic fibrosis with gadoteridol (ProHance) in patients who are on long-term hemodialysis

1 reference

12 December 2020

Comparison of Gd DTPA-BMA (Omniscan) versus Gd HP-DO3A (ProHance) retention in human bone tissue by inductively coupled plasma atomic emission spectroscopy

1 reference

12 December 2020

Scleromyxoedema-like changes in four renal dialysis patients

1 reference

12 December 2020

Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure

1 reference

12 December 2020

Nephrogenic Systemic Fibrosis: A Mysterious Disease in Patients with Renal Failure--Role of Gadolinium-Based Contrast Media in Causation and the Beneficial Effect of Intravenous Sodium Thiosulfate

1 reference

12 December 2020

Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR).

1 reference

12 December 2020

Renal transplant failure due to urologic complications: Comparison of static fluid with contrast-enhanced magnetic resonance urography.

1 reference

12 December 2020

Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort

1 reference

12 December 2020

Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

1 reference

12 December 2020

Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease).

1 reference

12 December 2020

Nephrogenic Fibrosing Dermopathy: An Unusual Skin Condition Associated with Kidney Disease

1 reference

12 December 2020

Nephrogenic fibrosing dermopathy associated with exposure to gadolinium-containing contrast agents--St. Louis, Missouri, 2002-2006

1 reference

12 December 2020

In support of the European Union biosimilar framework

1 reference

12 December 2020

Clinical and pathologic features of nephrogenic fibrosing dermopathy: a report of two cases

1 reference

12 December 2020

Nephrogenic fibrosing dermopathy after liver transplantation successfully treated with plasmapheresis

1 reference

12 December 2020

Response to "Will dialysis prevent the development of nephrogenic systemic fibrosis after gadolinium-based contrast administration?".

1 reference

12 December 2020

Nephrogenic fibrosing dermopathy: response to high-dose intravenous immunoglobulin.

1 reference

12 December 2020

Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned

1 reference

12 December 2020

A pediatric case of nephrogenic fibrosing dermopathy: improvement after combination therapy.

1 reference

12 December 2020

Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging

1 reference

12 December 2020

Successful treatment of three cases of nephrogenic fibrosing dermopathy with extracorporeal photopheresis

1 reference

12 December 2020

Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis

1 reference

12 December 2020

Automated scanning electron microscopy and x-ray microanalysis for in situ quantification of gadolinium deposits in skin

1 reference

12 December 2020

Good MRI images: to Gad or not to Gad?

1 reference

12 December 2020

UV-A1 phototherapy improves nephrogenic fibrosing dermopathy

1 reference

12 December 2020

Nephrogenic fibrosing dermopathy in a patient with systemic lupus erythematosus and acute lupus nephritis

1 reference

12 December 2020

Scleromyxoedema-like cutaneous diseases in renal-dialysis patients

1 reference

12 December 2020

Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review

1 reference

12 December 2020

Nephrogenic fibrosing dermopathy: the first 6 years

1 reference

12 December 2020

Dialyzability of gadodiamide in hemodialysis patients

1 reference

12 December 2020

Nephrogenic fibrosing dermopathy

1 reference

12 December 2020

Nephrogenic fibrosing dermopathy in children.

1 reference

12 December 2020

Gadolinium is not the only trigger for nephrogenic systemic fibrosis: insights from two cases and review of the recent literature

1 reference

12 December 2020

Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents.

1 reference

12 December 2020

What nephrologists need to know about gadolinium

1 reference

12 December 2020

Transglutaminases: the missing link in nephrogenic systemic fibrosis

1 reference

12 December 2020

Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure

1 reference

12 December 2020

Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin

1 reference

12 December 2020

Nephrogenic systemic fibrosis with multiorgan involvement in a teenage male after lymphoma, Ewing's sarcoma, end-stage renal disease, and hemodialysis

1 reference

12 December 2020

Nephrogenic fibrosing dermopathy: two pediatric cases

1 reference

12 December 2020

Histopathologic comparison of nephrogenic fibrosing dermopathy and scleromyxedema

1 reference

12 December 2020

Nephrogenic fibrosing dermopathy with systemic involvement

1 reference

12 December 2020

Dissociation of gadolinium chelates in mice: relationship to chemical characteristics

1 reference

12 December 2020

Involvement of skeletal muscle in dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy)

1 reference

12 December 2020

Gadolinium and nephrogenic systemic fibrosis.

1 reference

12 December 2020

Nephrogenic fibrosing dermopathy: suspect identified, motive unclear

1 reference

12 December 2020

The case for ultraviolet light therapy in nephrogenic fibrosing dermopathy--report of two cases and review of the literature

1 reference

12 December 2020

Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis

1 reference

12 December 2020

Neuromuscular involvement in nephrogenic systemic fibrosis

1 reference

12 December 2020

Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature

1 reference

12 December 2020

Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

[Nephrogenic fibrosing dermopathy treated with extracorporeal photopheresis: role of gadolinium?]

1 reference

12 December 2020

Multiorgan involvement in nephrogenic fibrosing dermopathy: an autopsy case and review of the literature

1 reference

12 December 2020

Treatment with corticosteroids does not seem to benefit nephrogenic systemic fibrosis

1 reference

12 December 2020

Nephrogenic fibrosing dermopathy in pediatric patients

1 reference

12 December 2020

Gadolinium and nephrogenic fibrosing dermopathy in pediatric patients

1 reference

12 December 2020

Are patients with moderate renal failure at risk for developing nephrogenic systemic fibrosis?

1 reference

12 December 2020

Nephrogenic fibrosing dermopathy treated with extracorporeal photopheresis

1 reference

12 December 2020

Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure.

1 reference

12 December 2020

Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure

1 reference

12 December 2020

Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure.

1 reference

12 December 2020

Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosis

1 reference

12 December 2020

Nephrogenic systemic fibrosis following the administration of extracellular gadolinium based contrast agents: is the stability of the contrast agent molecule an important factor in the pathogenesis of this condition?

1 reference

12 December 2020

Nephrogenic systemic fibrosis: risk factors and incidence estimation.

1 reference

12 December 2020

10.1007/S00467-008-0862-6

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18543004